Pharmacological assessment of the antineoplastic and immunomodulatory properties of a new spiroindolone derivative (7’,8’-Dimethoxy-1’,3’-dimethyl-1,2,3’,4’-tetrahydrospiro[indole-3,5’-pyrazolo[3,4-c]isoquinolin]-2-one) in chronic myeloid leukemia Carlos Eduardo de Castro AlvesSerge L. BogzaGemilson Soares Pontes Research 15 July 2023 Pages: 629 - 637
Development of novel palbociclib-based CDK4/6 inhibitors exploring the back pocket behind the gatekeeper Lina LiFengquan ChenXia Xue Research 20 July 2023 Pages: 638 - 651
Development and characterization of fused human arginase I for cancer therapy Snehal Sainath JawalekarPriyanka Sugriv KawatheAbhay H. Pande Research 03 August 2023 Pages: 652 - 663
Enhanced antitumor and anti-metastasis by VEGFR2-targeted doxorubicin immunoliposome synergy with NK cell activation Mingzhu PanYali LiuJuan Zhang Research 05 August 2023 Pages: 664 - 676
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study Rebecca KristeleitAlexandra LearyVivek Subbiah Research Open access 09 August 2023 Pages: 677 - 687
Cytotoxicity of poly-guanidine in medulloblastoma cell lines Gabriel Gallo-OllerTeresita Díaz de StåhlMarcela Márquez-Méndez Research Open access 09 August 2023 Pages: 688 - 698
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models Rachel C.T. LamConnie W.C. HuiBrigette B.Y. Ma Research 12 August 2023 Pages: 699 - 709
Efficacy, safety, and cost-minimization analysis of axicabtagene ciloleucel and tisagenlecleucel CAR T-Cell therapies for treatment of relapsed or refractory follicular lymphoma Buthainah Ghanem Research Open access 12 August 2023 Pages: 710 - 718
Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinoma Zhao GaoShikai WuXuan Jin Research 17 August 2023 Pages: 719 - 726
Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab Markus HaasAlexander LeinBernhard J. Jank Research Open access 21 August 2023 Pages: 727 - 736
A novel bivalent anti-c-MET/PD-1 bispecific antibody exhibits potent cytotoxicity against c-MET/PD-L1-positive colorectal cancer Z. SunC. GuD. Li Research 30 August 2023 Pages: 737 - 750
A novel anticancer quinolone, (R)-WAC-224, has anti-leukemia activities against acute myeloid leukemia Tatsuji MinoHiroshi UreshinoTatsuo Ichinohe Research 13 September 2023 Pages: 751 - 760
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma Kenta YamaokaKei IrieNobuyuki Muroi Research Open access 18 September 2023 Pages: 761 - 767
The efficacy and safety of selective RET inhibitors in RET fusion-positive non-small cell lung cancer: a meta-analysis Jun-yi KeShu HuangMin-chao Duan Review Open access 21 August 2023 Pages: 768 - 776